Asenapine maleate transdermal patch: Phase III started

Hisamitsu’s Noven Pharmaceuticals Inc. subsidiary began a double-blind, placebo-controlled, international Phase III trial to evaluate 2 dose levels of asenapine maleate transdermal patches in about 6...